文献速递艾滋病与性传播感染

多替拉韦通过破坏棕色/米色脂肪细胞解偶联蛋白1表达及线粒体功能抑制产热:临床前模型研究

Dolutegravir Suppresses Thermogenesis via Disrupting Uncoupling Protein 1 Expression and Mitochondrial Function in Brown/Beige Adipocytes in Preclinical Models.
PubMed 文献 · J Infect Dis · 2022-01-01

该临床前研究探讨多替拉韦(DTG)对雌性小鼠能量消耗及棕色/米色脂肪细胞的影响。结果显示,DTG给药两周降低小鼠能量消耗并下调棕色/米色脂肪组织解偶联蛋白1(UCP1)表达;体外实验中DTG显著降低棕色和米色脂肪细胞UCP1等棕色成脂标志物,并导致线粒体复合物IV成分减少、呼吸能力下降及胰岛素刺激的葡萄糖摄取减少。作者认为DTG靶向UCP1和线粒体功能,可能是其抑制能量消耗导致体重增加的潜在机制。

要点

  • 雌性小鼠给予DTG两周后能量消耗降低,伴棕色/米色脂肪组织UCP1表达下降
  • 体外DTG显著降低棕色和米色脂肪细胞UCP1等棕色成脂标志物,其他类别药物无此作用
  • DTG导致UCP1丢失后线粒体复合物IV成分减少、呼吸能力下降及胰岛素刺激葡萄糖摄取减少

核心结论

  • 作者认为DTG靶向棕色和米色脂肪细胞的UCP1及线粒体功能,在临床前模型中破坏产热功能,提供DTG抑制能量消耗导致体重增加的潜在机制。

研究设计与样本

  • 临床前研究:评估DTG对雌性小鼠摄食、能量消耗、耗氧量及脂肪组织基因表达的影响。
  • 体外用人及鼠前脂肪细胞,在分化为成熟棕色/米色脂肪细胞过程中或分化后给予DTG处理。
  • 分析脂质蓄积、脂解、β肾上腺素能反应、成脂标志物、线粒体呼吸及胰岛素反应。

主要发现

  • 雌性小鼠给予DTG两周后能量消耗降低,伴棕色/米色脂肪组织UCP1表达下降。
  • 体外DTG显著降低棕色和米色脂肪细胞棕色成脂标志物尤其UCP1,其他类别药物无此作用。
  • DTG致UCP1丢失后线粒体复合物IV成分减少,继而线粒体呼吸能力下降、胰岛素刺激的葡萄糖摄取减少。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antiretroviral therapy (ART) containing integrase strand transfer inhibitors (INSTIs) has been associated with weight gain in both ART initiation and switch studies, especially in women, but the underlying mechanisms are unclear. METHODS: The effects of dolutegravir (DTG) on food intake, energy expenditure, oxygen consumption in female mice, and gene expression from adipose tissues were assessed. Human and murine preadipocytes were treated with DTG either during differentiation into mature brown/beige adipocytes or postdifferentiation. Lipid accumulation, lipolysis, β-adrenergic response, adipogenic markers, mitochondrial respiration, and insulin response were analyzed. RESULTS: Two-week administration of DTG to female mice reduced energy expenditure, which was accompanied by decreased uncoupling protein 1 (UCP1) expression in brown/beige adipose tissues. In vitro studies showed that DTG significantly reduced brown adipogenic markers, especially UCP1 in brown and beige adipocytes, whereas drugs from other classes did not. Furthermore, a loss of UCP1 by DTG led to a decrease in mitochondrial complex IV component, followed by a reduction in mitochondrial respiratory capacity and reduced insulin-stimulated glucose uptake. CONCLUSIONS: Our findings show that DTG targets UCP1 and mitochondrial functions in brown and beige adipocytes and disrupts thermogenic functions in preclinical models, providing the potential mechanisms by which DTG suppresses energy expenditure leading to weight gain.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Jung I, Tu-Sekine B, Jin S, et al. Dolutegravir Suppresses Thermogenesis via Disrupting Uncoupling Protein 1 Expression and Mitochondrial Function in Brown/Beige Adipocytes in Preclinical Models. J Infect Dis. 2022. PMID: 35512127. doi:10.1093/infdis/jiac175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。